Viewing StudyNCT00168753



Ignite Creation Date: 2024-05-05 @ 11:53 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00168753
Status: COMPLETED
Last Update Posted: 2014-09-08
First Post: 2005-09-13

Brief Title: Community Based Trial for AMEVIVE
Sponsor: Astellas Pharma Inc
Organization: Astellas Pharma Inc

Conditions & Keywords Data

Conditions:
Name
Moderate to Severe Chronic Plaque Psoriasis
Keywords:
Name View
alefacept View
Extended dosing View